(Total Views: 78)
Posted On: 05/23/2023 12:10:50 PM
Post# of 144622
$MEIP News Article - MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies https://marketwirenews.com/news-releases/mei-...49067.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
